Australia markets close in 2 hours 53 minutes

LifeMD, Inc. (LFMD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.21+0.34 (+3.44%)
At close: 04:00PM EDT
10.41 +0.20 (+1.96%)
After hours: 07:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 385.41M
Enterprise value 371.20M
Trailing P/E N/A
Forward P/E 32.89
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.19
Price/book (mrq)109.95
Enterprise value/revenue 2.43
Enterprise value/EBITDA -47.05

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 3500.59%
S&P500 52-week change 321.23%
52-week high 312.01
52-week low 31.40
50-day moving average 38.79
200-day moving average 36.56

Share statistics

Avg vol (3-month) 3646.6k
Avg vol (10-day) 3499.29k
Shares outstanding 539.09M
Implied shares outstanding 639.2M
Float 830.96M
% held by insiders 119.81%
% held by institutions 130.91%
Shares short (28 Mar 2024) 42.65M
Short ratio (28 Mar 2024) 42.89
Short % of float (28 Mar 2024) 48.04%
Short % of shares outstanding (28 Mar 2024) 46.78%
Shares short (prior month 29 Feb 2024) 42.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Oct 2020
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 314 Oct 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -13.50%
Operating margin (ttm)-4.84%

Management effectiveness

Return on assets (ttm)-21.52%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)152.55M
Revenue per share (ttm)4.50
Quarterly revenue growth (yoy)59.50%
Gross profit (ttm)N/A
EBITDA -13.31M
Net income avi to common (ttm)-23.7M
Diluted EPS (ttm)-0.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.15M
Total cash per share (mrq)0.82
Total debt (mrq)18.93M
Total debt/equity (mrq)340.13%
Current ratio (mrq)1.23
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)8.82M
Levered free cash flow (ttm)3.94M